Voyager Therapeutics (VYGR) EBITDA Margin Growth (3y) (2018 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | -101,581.00 |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 4.62 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | -20,903.00 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 179,305.00 |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | -2.53 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 123,643.00 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 5,442.00 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 1,354.00 |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - | -30,585.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -30,585.00 |
| Mar 31, 2026 | -124,589.00 |
| Dec 31, 2025 | -177,988.00 |
| Sep 30, 2025 | -26,346.00 |
| Jun 30, 2025 | 201,576.00 |
| Mar 31, 2025 | 271,094.00 |
| Dec 31, 2024 | -63,036.00 |
| Sep 30, 2024 | 164,081.00 |
| Jun 30, 2024 | 205,572.00 |
| Mar 31, 2024 | 31,069.00 |
| Dec 31, 2023 | 42,302.00 |
| Sep 30, 2023 | -71,124.00 |
| Jun 30, 2023 | -48,758.00 |
| Mar 31, 2023 | 21,690.00 |
| Dec 31, 2022 | 162,685.00 |
| Sep 30, 2022 | 12,230.00 |
| Jun 30, 2022 | -274,002.00 |
| Mar 31, 2022 | -268,103.00 |
| Dec 31, 2021 | 117,375.00 |
| Sep 30, 2021 | -68,688.00 |